BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12401722)

  • 21. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations.
    Dullaart RP; De Vries R; Scheek L; Borggreve SE; Van Gent T; Dallinga-Thie GM; Ito M; Nagano M; Sluiter WJ; Hattori H; Van Tol A
    Scand J Clin Lab Invest; 2004; 64(3):205-15. PubMed ID: 15222630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity.
    Huuskonen J; Ekström M; Tahvanainen E; Vainio A; Metso J; Pussinen P; Ehnholm C; Olkkonen VM; Jauhiainen M
    Atherosclerosis; 2000 Aug; 151(2):451-61. PubMed ID: 10924722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
    Dullaart RPF; Gruppen EG; Dallinga-Thie GM
    Clin Biochem; 2016 Apr; 49(6):508-510. PubMed ID: 26656640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y
    Eur J Clin Invest; 2003 Apr; 33(4):301-6. PubMed ID: 12662160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y; Tam S
    Atherosclerosis; 2005 Feb; 178(2):365-70. PubMed ID: 15754464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.
    Lusa S; Jauhiainen M; Metso J; Somerharju P; Ehnholm C
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):275-82. PubMed ID: 8546695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
    Rao R; Albers JJ; Wolfbauer G; Pownall HJ
    Biochemistry; 1997 Mar; 36(12):3645-53. PubMed ID: 9132017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate.
    Bouly M; Masson D; Gross B; Jiang XC; Fievet C; Castro G; Tall AR; Fruchart JC; Staels B; Lagrost L; Luc G
    J Biol Chem; 2001 Jul; 276(28):25841-7. PubMed ID: 11342537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects.
    Dullaart RP; van Tol A
    Scand J Clin Lab Invest; 2001 Feb; 61(1):69-74. PubMed ID: 11300613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reduction of lipoproteins with apoAI but without apoAII (LpAI) in non-insulin-dependent diabetic patients].
    Barkia A; Zouari N; Khrouf W; Ellouz F; Zouaghi H
    Ann Biol Clin (Paris); 1996; 54(2):83-6. PubMed ID: 8763631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
    Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive.
    Oka T; Kujiraoka T; Ito M; Egashira T; Takahashi S; Nanjee MN; Miller NE; Metso J; Olkkonen VM; Ehnholm C; Jauhiainen M; Hattori H
    J Lipid Res; 2000 Oct; 41(10):1651-7. PubMed ID: 11013307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of weight loss on PLTP activity and HDL particle size.
    Kaser S; Laimer M; Sandhofer A; Salzmann K; Ebenbichler CF; Patsch JR
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1280-2. PubMed ID: 15365582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pig plasma phospholipid transfer protein facilitates HDL interconversion.
    Pussinen P; Jauhianinen M; Metso J; Tyynelä J; Ehnholm C
    J Lipid Res; 1995 May; 36(5):975-85. PubMed ID: 7658169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation.
    Jaari S; van Dijk KW; Olkkonen VM; van der Zee A; Metso J; Havekes L; Jauhiainen M; Ehnholm C
    Comp Biochem Physiol B Biochem Mol Biol; 2001 Apr; 128(4):781-92. PubMed ID: 11290460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response.
    Barlage S; Fröhlich D; Böttcher A; Jauhiainen M; Müller HP; Noetzel F; Rothe G; Schütt C; Linke RP; Lackner KJ; Ehnholm C; Schmitz G
    J Lipid Res; 2001 Feb; 42(2):281-90. PubMed ID: 11181759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion.
    Huuskonen J; Olkkonen VM; Ehnholm C; Metso J; Julkunen I; Jauhiainen M
    Biochemistry; 2000 Dec; 39(51):16092-8. PubMed ID: 11123937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of human plasma phospholipid transfer protein by sandwich ELISA.
    Oka T; Kujiraoka T; Ito M; Nagano M; Ishihara M; Iwasaki T; Egashira T; Miller NE; Hattori H
    Clin Chem; 2000 Sep; 46(9):1357-64. PubMed ID: 10973866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.